2025 Q3 -tulosraportti
Vain PDF
110 päivää sitten
Tarjoustasot
Määrä
Osto
38
Myynti
Määrä
4 617
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Ylin
0,288VWAP
Alin
0,271VaihtoMäärä
0,8 4 145 815
VWAP
Ylin
0,288Alin
0,271VaihtoMäärä
0,8 4 145 815
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2025 Q4 -tulosraportti 12.3. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q3 -tulosraportti 30.10.2025 | ||
2025 Q2 -tulosraportti 14.8.2025 | ||
2025 Q1 -tulosraportti 30.5.2025 | ||
2024 Q4 -tulosraportti 27.3.2025 | ||
2024 Q3 -tulosraportti 14.11.2024 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·13.2.Not bad to see progress on a Friday evening 😎 Happy weekend, everyone!
·13.2. · MuokattuSoon we will find out whether the PLA code has been approved or not, but it seems highly probable that it will be approved. By Friday 20/2 at the latest, PSTV will receive notification, and the results will be published on AMA's website, so I guess they will send out a press release by Monday 23/2 at the latest, but probably during the coming week. Source for date: https://www.ama-assn.org/system/files/cpt-panel-february-2026-agenda.pdf Published codes: https://www.ama-assn.org/practice-management/cpt/cpt-pla-codes Currently, they have a temporary CPT code that is used for billing, a generic code that doesn't quite describe the specific test for CNSide. When the PLA code is approved, it is still just a shell without a fixed price. The difference here is that PSTV gets a code directly linked to CNSide, which describes the test and enables a higher reimbursement rate, even though there isn't a fixed price yet. Simplified, it's a bit like a seal of quality. This is an extremely important milestone for CNSide, and we can hope that it clears up a lot of question marks from the market. This also opens up for greater coverage via Medicare, as well as other insurance companies. It also starts the process to be able to get coverage via Medicaid, but as far as I understand, it requires a fixed price tag on their PLA code, i.e., an evaluation of exactly how much the test is worth, and this is a process that extends all the way until the turn of the year.
·4.2.I'm down 65% on this stock. Is there any good news to be found anywhere?
·5.2.According to ChatGPT, institutional (SMART MONEY) forces are at play right now. They have been in the picture before, whether they withdrew or failed to defend the price is a good question. Right now, it looks like they are not allowing a close below 0.24 and I can only imagine that the target will slowly be raised. At some point, if SMART MONEY is persistent, they will start to break resistance zones, allow a pullback to happen, and then take the next step (based on technical analysis). I myself have plenty in this stock, with a large loss, but I actually bought into my investment savings account today, so I haven't given up; this despite the fact that much is affected by geopolitical unrest, tariffs, and signals of a generally changed currency structure😊 I'm actually a bit cautious right now!- ·1.2.From Reddit and ChatGPT’s translation and explanation. Translation (from English to Danish) Ownership in Plus Therapeutics is changing On January 22, 2026, CVI Investments, Inc. and Heights Capital Management, Inc. filed a so-called Schedule 13G, reporting that they own 12,368,423 shares, corresponding to 6.9% of the outstanding shares in Plus Therapeutics at the time of the filing. Heights Capital acts as investment manager for CVI Investments, and the filing indicates that the position is held passively (i.e., without active influence on management). A disclosed ownership stake of almost 7% is significant for a company of this size and was not present previously. Total non-private (institutional) ownership is currently 10–12%. 6 months ago, it was only 1–2%. Edit: It is only logical to think that they are currently partially involved in the capital increase (issuance). ⸻ 🧠 What does this mean in practice? Short version: It's a clear signal of increasing institutional interest – and that's usually positive. 🔍 More detailed explanation: 1️⃣ Large professional investors have entered • CVI / Heights Capital are not private small investors, but professional asset managers. • That they own almost 7% of the company is a lot for a small biotech company. 2️⃣ “Passive” does not mean uninterested • “Passive” just means that they are not officially trying to control the company. • In practice, such investors still keep a close eye on developments. 3️⃣ Institutional ownership has increased significantly • From 1–2% → 10–12% in 6 months • This is a drastic change and suggests that “smart money” is positioning itself. 4️⃣ Probable connection with capital raising • The comment about the “offering” means: • They may have helped finance the company • This reduces the risk for Plus Therapeutics and increases the chances of survival ⸻ 📈 Why do many investors see this as bullish? ✔️ Professional money rarely enters without reason ✔️ Increases credibility with the market ✔️ Less likelihood of total collapse ✔️ Can lead to more stable share price and future interest ⸻ ⚠️ Small but important note It is not a guarantee of a price increase, but: 👉 It is a seal of approval and a sign that the company is being taken more seriously than before.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Ei uutisia tällä hetkellä
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q3 -tulosraportti
Vain PDF
110 päivää sitten
Uutiset
Ei uutisia tällä hetkellä
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·13.2.Not bad to see progress on a Friday evening 😎 Happy weekend, everyone!
- ·13.2. · MuokattuSoon we will find out whether the PLA code has been approved or not, but it seems highly probable that it will be approved. By Friday 20/2 at the latest, PSTV will receive notification, and the results will be published on AMA's website, so I guess they will send out a press release by Monday 23/2 at the latest, but probably during the coming week. Source for date: https://www.ama-assn.org/system/files/cpt-panel-february-2026-agenda.pdf Published codes: https://www.ama-assn.org/practice-management/cpt/cpt-pla-codes Currently, they have a temporary CPT code that is used for billing, a generic code that doesn't quite describe the specific test for CNSide. When the PLA code is approved, it is still just a shell without a fixed price. The difference here is that PSTV gets a code directly linked to CNSide, which describes the test and enables a higher reimbursement rate, even though there isn't a fixed price yet. Simplified, it's a bit like a seal of quality. This is an extremely important milestone for CNSide, and we can hope that it clears up a lot of question marks from the market. This also opens up for greater coverage via Medicare, as well as other insurance companies. It also starts the process to be able to get coverage via Medicaid, but as far as I understand, it requires a fixed price tag on their PLA code, i.e., an evaluation of exactly how much the test is worth, and this is a process that extends all the way until the turn of the year.
- ·4.2.I'm down 65% on this stock. Is there any good news to be found anywhere?·5.2.According to ChatGPT, institutional (SMART MONEY) forces are at play right now. They have been in the picture before, whether they withdrew or failed to defend the price is a good question. Right now, it looks like they are not allowing a close below 0.24 and I can only imagine that the target will slowly be raised. At some point, if SMART MONEY is persistent, they will start to break resistance zones, allow a pullback to happen, and then take the next step (based on technical analysis). I myself have plenty in this stock, with a large loss, but I actually bought into my investment savings account today, so I haven't given up; this despite the fact that much is affected by geopolitical unrest, tariffs, and signals of a generally changed currency structure😊 I'm actually a bit cautious right now!
- ·1.2.From Reddit and ChatGPT’s translation and explanation. Translation (from English to Danish) Ownership in Plus Therapeutics is changing On January 22, 2026, CVI Investments, Inc. and Heights Capital Management, Inc. filed a so-called Schedule 13G, reporting that they own 12,368,423 shares, corresponding to 6.9% of the outstanding shares in Plus Therapeutics at the time of the filing. Heights Capital acts as investment manager for CVI Investments, and the filing indicates that the position is held passively (i.e., without active influence on management). A disclosed ownership stake of almost 7% is significant for a company of this size and was not present previously. Total non-private (institutional) ownership is currently 10–12%. 6 months ago, it was only 1–2%. Edit: It is only logical to think that they are currently partially involved in the capital increase (issuance). ⸻ 🧠 What does this mean in practice? Short version: It's a clear signal of increasing institutional interest – and that's usually positive. 🔍 More detailed explanation: 1️⃣ Large professional investors have entered • CVI / Heights Capital are not private small investors, but professional asset managers. • That they own almost 7% of the company is a lot for a small biotech company. 2️⃣ “Passive” does not mean uninterested • “Passive” just means that they are not officially trying to control the company. • In practice, such investors still keep a close eye on developments. 3️⃣ Institutional ownership has increased significantly • From 1–2% → 10–12% in 6 months • This is a drastic change and suggests that “smart money” is positioning itself. 4️⃣ Probable connection with capital raising • The comment about the “offering” means: • They may have helped finance the company • This reduces the risk for Plus Therapeutics and increases the chances of survival ⸻ 📈 Why do many investors see this as bullish? ✔️ Professional money rarely enters without reason ✔️ Increases credibility with the market ✔️ Less likelihood of total collapse ✔️ Can lead to more stable share price and future interest ⸻ ⚠️ Small but important note It is not a guarantee of a price increase, but: 👉 It is a seal of approval and a sign that the company is being taken more seriously than before.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
38
Myynti
Määrä
4 617
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Ylin
0,288VWAP
Alin
0,271VaihtoMäärä
0,8 4 145 815
VWAP
Ylin
0,288Alin
0,271VaihtoMäärä
0,8 4 145 815
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2025 Q4 -tulosraportti 12.3. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q3 -tulosraportti 30.10.2025 | ||
2025 Q2 -tulosraportti 14.8.2025 | ||
2025 Q1 -tulosraportti 30.5.2025 | ||
2024 Q4 -tulosraportti 27.3.2025 | ||
2024 Q3 -tulosraportti 14.11.2024 |
2025 Q3 -tulosraportti
Vain PDF
110 päivää sitten
Uutiset
Ei uutisia tällä hetkellä
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2025 Q4 -tulosraportti 12.3. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q3 -tulosraportti 30.10.2025 | ||
2025 Q2 -tulosraportti 14.8.2025 | ||
2025 Q1 -tulosraportti 30.5.2025 | ||
2024 Q4 -tulosraportti 27.3.2025 | ||
2024 Q3 -tulosraportti 14.11.2024 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·13.2.Not bad to see progress on a Friday evening 😎 Happy weekend, everyone!
- ·13.2. · MuokattuSoon we will find out whether the PLA code has been approved or not, but it seems highly probable that it will be approved. By Friday 20/2 at the latest, PSTV will receive notification, and the results will be published on AMA's website, so I guess they will send out a press release by Monday 23/2 at the latest, but probably during the coming week. Source for date: https://www.ama-assn.org/system/files/cpt-panel-february-2026-agenda.pdf Published codes: https://www.ama-assn.org/practice-management/cpt/cpt-pla-codes Currently, they have a temporary CPT code that is used for billing, a generic code that doesn't quite describe the specific test for CNSide. When the PLA code is approved, it is still just a shell without a fixed price. The difference here is that PSTV gets a code directly linked to CNSide, which describes the test and enables a higher reimbursement rate, even though there isn't a fixed price yet. Simplified, it's a bit like a seal of quality. This is an extremely important milestone for CNSide, and we can hope that it clears up a lot of question marks from the market. This also opens up for greater coverage via Medicare, as well as other insurance companies. It also starts the process to be able to get coverage via Medicaid, but as far as I understand, it requires a fixed price tag on their PLA code, i.e., an evaluation of exactly how much the test is worth, and this is a process that extends all the way until the turn of the year.
- ·4.2.I'm down 65% on this stock. Is there any good news to be found anywhere?·5.2.According to ChatGPT, institutional (SMART MONEY) forces are at play right now. They have been in the picture before, whether they withdrew or failed to defend the price is a good question. Right now, it looks like they are not allowing a close below 0.24 and I can only imagine that the target will slowly be raised. At some point, if SMART MONEY is persistent, they will start to break resistance zones, allow a pullback to happen, and then take the next step (based on technical analysis). I myself have plenty in this stock, with a large loss, but I actually bought into my investment savings account today, so I haven't given up; this despite the fact that much is affected by geopolitical unrest, tariffs, and signals of a generally changed currency structure😊 I'm actually a bit cautious right now!
- ·1.2.From Reddit and ChatGPT’s translation and explanation. Translation (from English to Danish) Ownership in Plus Therapeutics is changing On January 22, 2026, CVI Investments, Inc. and Heights Capital Management, Inc. filed a so-called Schedule 13G, reporting that they own 12,368,423 shares, corresponding to 6.9% of the outstanding shares in Plus Therapeutics at the time of the filing. Heights Capital acts as investment manager for CVI Investments, and the filing indicates that the position is held passively (i.e., without active influence on management). A disclosed ownership stake of almost 7% is significant for a company of this size and was not present previously. Total non-private (institutional) ownership is currently 10–12%. 6 months ago, it was only 1–2%. Edit: It is only logical to think that they are currently partially involved in the capital increase (issuance). ⸻ 🧠 What does this mean in practice? Short version: It's a clear signal of increasing institutional interest – and that's usually positive. 🔍 More detailed explanation: 1️⃣ Large professional investors have entered • CVI / Heights Capital are not private small investors, but professional asset managers. • That they own almost 7% of the company is a lot for a small biotech company. 2️⃣ “Passive” does not mean uninterested • “Passive” just means that they are not officially trying to control the company. • In practice, such investors still keep a close eye on developments. 3️⃣ Institutional ownership has increased significantly • From 1–2% → 10–12% in 6 months • This is a drastic change and suggests that “smart money” is positioning itself. 4️⃣ Probable connection with capital raising • The comment about the “offering” means: • They may have helped finance the company • This reduces the risk for Plus Therapeutics and increases the chances of survival ⸻ 📈 Why do many investors see this as bullish? ✔️ Professional money rarely enters without reason ✔️ Increases credibility with the market ✔️ Less likelihood of total collapse ✔️ Can lead to more stable share price and future interest ⸻ ⚠️ Small but important note It is not a guarantee of a price increase, but: 👉 It is a seal of approval and a sign that the company is being taken more seriously than before.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
38
Myynti
Määrä
4 617
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Ylin
0,288VWAP
Alin
0,271VaihtoMäärä
0,8 4 145 815
VWAP
Ylin
0,288Alin
0,271VaihtoMäärä
0,8 4 145 815
Välittäjätilasto
Dataa ei löytynyt